structural elucidation1>2). In the fermentation of this bacterium, we found that the composition of the products varied depending on the culture phase. In the middle or late phase of fermentation the main product is 1; whereas another compound, distinguished from 1 was produced in the early phase. This substance was eluted more rapidly than 1 in reversed-phase HPLC (CH3CN-H2O-HCOOH, 1,000:
1,200:6.6) and its biological and physicochemical properties seemed to be quite similar to those of 1. We isolated and purified this product according to our previous paper3) and namedit enacyloxin IVa (ENX IVa, 2).
In this paper, we describe the isolation and chemical structure of 2. The supernatant obtained by centrifugation of culture broth was extracted with ether after acidifying it with HC1to pH 2. The ether solution was then back-extracted with 1 % NaHCO3. An aqueous layer was acidified and re-extracted with ether. After evaporation of the solvent in vacuo, the residue was purified successively by preparative :CH-x2, :CH-X (X=O or Cl)x8, -CH= x10, :C= x2,-COORx 1,-COOHx 1 and -OCONH2x 1). The signal of ketone (211.7ppm) in 1 disappeared in 2, but eight oxymethines were observed in 2 instead of the seven in 1. These observations allowed us to anticipate that 2 would be a structurally related congener of 1 with a reduced functionality at C-15'. The arrangement of carbon skeleton and functional groups was elucidated by detailed analysis of *H NMRspectra measured at 400MHz. Phase-sensitive double quantum filter COSY spectra revealed the presence of spin networks of cyclohexane moiety, 2 -H~5'-H, 7-Hl O'-H and 12 -H~23'-H. As expected, methylene protons at 16', 17-H, 14'-H and 13'-H shifted to the higher magnetic fields and the new oxymethine proton of 15'-H was observed at 3.89ppm. Other signals including olefinic ones were easily assigned from similarities to those of 1.
In conclusion, the chemical structure of newly isolated antibiotic enacyloxin IVa was determined to be (2' £,4' £;6' £,8' £, 1 0' Z,20' £>3-(1 9' -carbamoyloxy-1 1',18'-dichloro-6',12'-dimethyl-13',14', 15' , 1T-tetrahydroxytricosa-2',4',6',8', 10',20'-hexaenoyl- oxy)-4-hydroxy-l-cyclohexanecarboxylic acid. It is noteworthy that, as mentioned above, 2 is the main product in the early phase of fermentation and 1 is that of the middle or late phase. Our unpublished data suggest that the amount of2 in the early phase of culture decreased with the increase of 1 with the lapse of fermentation time and also suggest that these changes in the products seemed to be stoichiometric. It seemed likely therefore that, in the fermentation by Frateuria sp. W-315, 2 is probably the biosynthetic precursor to 1. As for biological activities, 2 was active against
Gram-positive and Gram-negative bacteria, but inactive against yeasts and fungi. MICagainst E.
coli K-12 was shown to be 5.5/xg/ml. These properties were quite similar to those of 1.
